Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: University of North Carolina-Chapel Hill: Development and Application of Biomarkers of Exposure

Superfund Research Program

Development and Application of Biomarkers of Exposure

Project Leader: Stephen M. Rappaport (University of California-Berkeley)
Grant Number: P42ES005948
Funding Period: 1995 - 2011

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Progress Reports

Year:   2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995 

Over the past year, as part of its investigation of biomarkers of benzene exposure, this project has produced the first unambiguous evidence that benzene oxide (BO) is the primary product of benzene metabolism in rats and is sufficiently stable to be released in significant quantities from hepatocytes into the systemic circulation following metabolism of benzene. It also provides the first evidence that BO produces Hb adducts in humans exposed to benzene and supports the use of BO-Hb as a biomarker of human exposure to benzene. This latter finding arose from collaboration with the National Cancer Institute, which is conducting a major epidemiological investigation of benzene-exposed workers in China.

This project has also shown that differences in metabolism of pentachlorophenol (PCP) in rats and mice lead to different reactive intermediates in the livers of these animals (Cl4-1,2-Benzoquinone and Cl4-1,4-Benzoquinone were the major binding species in mouse liver, whereas in rats Cl4-1,2-Benzosemiquinone and Cl4-1,4-Benzoquinone predominated and no adducts of Cl4-1,2-Benzoquinone were detected). This difference in metabolism leads to much greater binding of reactive intermediates in the nuclei of mouse livers compared to rat livers and offers a plausible explanation of the observation that PCP produces hepatic tumors in mice but not rats.

to Top